Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun 6;10(3):306-313.
doi: 10.14744/nci.2022.54189. eCollection 2023.

Are follistatin-like protein 1 and follistatin-like protein 3 associated with inflammatory processes in patients with familial Mediterranean fever?

Huseyin Kaplan  1 , Mustafa Calis  2 , Cevat Yazici  3 , Inayet Gunturk  4 , Isa Cuce  2 , Abdurrahman Soner Senel  5
Affiliations

Are follistatin-like protein 1 and follistatin-like protein 3 associated with inflammatory processes in patients with familial Mediterranean fever?

Huseyin Kaplan et al. North Clin Istanb. .

Abstract

Objective: Follistatin-like protein 1 (FSTL-1) and follistatin-like protein 3 (FSTL-3) are glycoproteins whose associations with inflammatory cytokines were reported in previous studies. However, it is not yet known whether they have an effect on the pathogenesis of familial Mediterranean fever (FMF). We aimed to detect the FSTL-1 and FSTL-3 levels and to determine their relationship to the attack status and mutation types in patients with FMF.

Methods: Fifty-six FMF patients and 22 healthy controls (HCs) were included in the study. Serum FSTL-1 and FSTL-3 levels were measured with the enzyme-linked immunosorbent assay method from collected serum samples. In addition, the MEditerranean FeVer (MEFV) gene mutation types of the patients were noted.

Results: Serum FSTL-1 levels were significantly higher in FMF patients than in HCs (p=0.005). However, there was no significant difference in FSTL-1 levels between patients in the attack period (n=26) and in the attack-free period (n=30). FSTL-3 levels were similar between FMF patients and HCs or patients in the attack period and in the attack-free period. Furthermore, the MEFV mutation type and attack status had no significant effect on FSTL-1 and FSTL-3 levels (p>0.05).

Conclusion: Our results suggest that FSTL-1 may be associated with the pathogenesis of FMF, rather than FSTL-3. However, neither serum FSTL-1 nor FSTL-3 seems to be good markers to reflect inflammatory activity.

Keywords: Familial Mediterranean fever; follistatin-like protein 1; follistatin-like protein 3; inflammation; interleukin-1 beta.

PubMed Disclaimer

Conflict of interest statement

No conflict of interest was declared by the authors.

Similar articles

See all similar articles

References

    1. Onen F. Familial mediterranean fever. Rheumatol Int. 2006;26:489–96. - PubMed
    1. Dogan H, Akdemir F, Tasdemir S, Atis O, Diyarbakir E, Yildirim R, et al. A novel insertion mutation identified in exon 10 of the MEFV gene associated with Familial Mediterranean Fever. BMC Med Genet. 2014;15:74. - PMC - PubMed
    1. Jarjour RA, Dodaki R. Arthritis patterns in familial Mediterranean fever patients and association with M694V mutation. Mol Biol Rep. 2011;38:2033–36. - PubMed
    1. Petrushkin H, Stanford M, Fortune F, Jawad AS. Clinical review: familial mediterranean fever—an overview of pathogenesis, symptoms, ocular manifestations, and treatment. Ocul Immunol Inflamm. 2016;24:422–30. - PubMed
    1. Karadeniz H, Güler AA, Atas N, Satış H, Salman RB, Babaoglu H, et al. Tofacitinib for the treatment for colchicine-resistant familial Mediterranean fever: case-based review. Rheumatol Int. 2020;40:169–73. - PubMed